col1a1 Search Results


94
Thermo Fisher snp col1a1 c 25474005 10
Snp Col1a1 C 25474005 10, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/col1a1/pmc12940396-4-5--1?v=Thermo+Fisher
Average 94 stars, based on 1 article reviews
snp col1a1 c 25474005 10 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

94
R&D Systems pro collagen i alpha 1 pro cola1
Pro Collagen I Alpha 1 Pro Cola1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/col1a1/pmc11912118-190-5-25?v=R%26D+Systems
Average 94 stars, based on 1 article reviews
pro collagen i alpha 1 pro cola1 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

94
OriGene r1038 rabbit
R1038 Rabbit, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/col1a1/pm27083282-153-35-41?v=OriGene
Average 94 stars, based on 1 article reviews
r1038 rabbit - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

94
OriGene primary antibodies for col1a1
TGF-β secreted from the hiPSC-derived CM patch induced <t>Col1a1</t> expression but not Col3a1 (A) Schematic representation of the co-culture system. hiPSC-derived CMs were seeded on the upper chamber, whereas the cardiac fibroblasts isolated from mice heart were cultured at the lower chamber in the presence and absence of SB431542, a TGF-β receptor inhibitor. (B) RT-qPCR analysis of Col1a1 , Col3a1 , and Pai1 in the cultured cardiac fibroblasts. Two-way ANOVA (co-culture × inhibitor) with interaction; Tukey-adjusted post hoc tests on estimated marginal means. Data represent mean ± SEM. N = 3–6, one-way ANOVA followed by Tukey’s HSD test, p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.
Primary Antibodies For Col1a1, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/col1a1/pmc13053790-499-5-10?v=OriGene
Average 94 stars, based on 1 article reviews
primary antibodies for col1a1 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

93
OriGene ccn2
(A) Protein and (B) transcript expression levels of fibroblast activation marker (periostin) and ECM proteins (COL1A1, fibronectin, and <t>CCN2)</t> were increased in control (Scramble) HKFs following TGF-β1 (10 ng/mL) treatment. Knockdown of TXNDC5 attenuated the upregulation of these fibrogenic markers induced by TGF-β1 in HKFs (n = 5–10). (C) Overexpression of TXNDC5 was sufficient to induce upregulation of fibroblast activation marker (Periostin) and ECM proteins (COL1A1, fibronectin) in HKFs (n = 3–10). (D) Treatment of TGF-β1 (10 ng/mL) increased the cellular proliferation activity of HKFs, which was abrogated by TXNDC5 knockdown. (E) Overexpression of TXNDC5 increased the cellular proliferation activity of HKFs. In D and E, n = 10. Data are representative of 3 or more independent experimental replicates. For all panels, data are presented as mean ± SEM. The statistical significance of differences for 2 groups was determined by 2-sided t test and among 3 or more groups it was determined using 1-way ANOVA, followed by Sidak’s post hoc tests. *P < 0.05, **P < 0.01, ***P < 0.001.
Ccn2, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/col1a1/pmc07919722-545-16-19?v=OriGene
Average 93 stars, based on 1 article reviews
ccn2 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology sc 293182 mmp2 rabbit
(A) Protein and (B) transcript expression levels of fibroblast activation marker (periostin) and ECM proteins (COL1A1, fibronectin, and <t>CCN2)</t> were increased in control (Scramble) HKFs following TGF-β1 (10 ng/mL) treatment. Knockdown of TXNDC5 attenuated the upregulation of these fibrogenic markers induced by TGF-β1 in HKFs (n = 5–10). (C) Overexpression of TXNDC5 was sufficient to induce upregulation of fibroblast activation marker (Periostin) and ECM proteins (COL1A1, fibronectin) in HKFs (n = 3–10). (D) Treatment of TGF-β1 (10 ng/mL) increased the cellular proliferation activity of HKFs, which was abrogated by TXNDC5 knockdown. (E) Overexpression of TXNDC5 increased the cellular proliferation activity of HKFs. In D and E, n = 10. Data are representative of 3 or more independent experimental replicates. For all panels, data are presented as mean ± SEM. The statistical significance of differences for 2 groups was determined by 2-sided t test and among 3 or more groups it was determined using 1-way ANOVA, followed by Sidak’s post hoc tests. *P < 0.05, **P < 0.01, ***P < 0.001.
Sc 293182 Mmp2 Rabbit, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/col1a1/pmc08365028__mmc2-359-82-80?v=Santa+Cruz+Biotechnology
Average 96 stars, based on 1 article reviews
sc 293182 mmp2 rabbit - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier

95
Boster Bio collagen
(A) Protein and (B) transcript expression levels of fibroblast activation marker (periostin) and ECM proteins (COL1A1, fibronectin, and <t>CCN2)</t> were increased in control (Scramble) HKFs following TGF-β1 (10 ng/mL) treatment. Knockdown of TXNDC5 attenuated the upregulation of these fibrogenic markers induced by TGF-β1 in HKFs (n = 5–10). (C) Overexpression of TXNDC5 was sufficient to induce upregulation of fibroblast activation marker (Periostin) and ECM proteins (COL1A1, fibronectin) in HKFs (n = 3–10). (D) Treatment of TGF-β1 (10 ng/mL) increased the cellular proliferation activity of HKFs, which was abrogated by TXNDC5 knockdown. (E) Overexpression of TXNDC5 increased the cellular proliferation activity of HKFs. In D and E, n = 10. Data are representative of 3 or more independent experimental replicates. For all panels, data are presented as mean ± SEM. The statistical significance of differences for 2 groups was determined by 2-sided t test and among 3 or more groups it was determined using 1-way ANOVA, followed by Sidak’s post hoc tests. *P < 0.05, **P < 0.01, ***P < 0.001.
Collagen, supplied by Boster Bio, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/col1a1/pmc04517355-33-25-29?v=Boster+Bio
Average 95 stars, based on 1 article reviews
collagen - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier

93
OriGene anti collagen type i
(A) Protein and (B) transcript expression levels of fibroblast activation marker (periostin) and ECM proteins (COL1A1, fibronectin, and <t>CCN2)</t> were increased in control (Scramble) HKFs following TGF-β1 (10 ng/mL) treatment. Knockdown of TXNDC5 attenuated the upregulation of these fibrogenic markers induced by TGF-β1 in HKFs (n = 5–10). (C) Overexpression of TXNDC5 was sufficient to induce upregulation of fibroblast activation marker (Periostin) and ECM proteins (COL1A1, fibronectin) in HKFs (n = 3–10). (D) Treatment of TGF-β1 (10 ng/mL) increased the cellular proliferation activity of HKFs, which was abrogated by TXNDC5 knockdown. (E) Overexpression of TXNDC5 increased the cellular proliferation activity of HKFs. In D and E, n = 10. Data are representative of 3 or more independent experimental replicates. For all panels, data are presented as mean ± SEM. The statistical significance of differences for 2 groups was determined by 2-sided t test and among 3 or more groups it was determined using 1-way ANOVA, followed by Sidak’s post hoc tests. *P < 0.05, **P < 0.01, ***P < 0.001.
Anti Collagen Type I, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/col1a1/pm16537647-230-44-47?v=OriGene
Average 93 stars, based on 1 article reviews
anti collagen type i - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

93
Rockland Immunochemicals collagen type i
(A) Protein and (B) transcript expression levels of fibroblast activation marker (periostin) and ECM proteins (COL1A1, fibronectin, and <t>CCN2)</t> were increased in control (Scramble) HKFs following TGF-β1 (10 ng/mL) treatment. Knockdown of TXNDC5 attenuated the upregulation of these fibrogenic markers induced by TGF-β1 in HKFs (n = 5–10). (C) Overexpression of TXNDC5 was sufficient to induce upregulation of fibroblast activation marker (Periostin) and ECM proteins (COL1A1, fibronectin) in HKFs (n = 3–10). (D) Treatment of TGF-β1 (10 ng/mL) increased the cellular proliferation activity of HKFs, which was abrogated by TXNDC5 knockdown. (E) Overexpression of TXNDC5 increased the cellular proliferation activity of HKFs. In D and E, n = 10. Data are representative of 3 or more independent experimental replicates. For all panels, data are presented as mean ± SEM. The statistical significance of differences for 2 groups was determined by 2-sided t test and among 3 or more groups it was determined using 1-way ANOVA, followed by Sidak’s post hoc tests. *P < 0.05, **P < 0.01, ***P < 0.001.
Collagen Type I, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/col1a1/pmc08943153-603-0-20?v=Rockland+Immunochemicals
Average 93 stars, based on 1 article reviews
collagen type i - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

90
OriGene aortas
(A) Protein and (B) transcript expression levels of fibroblast activation marker (periostin) and ECM proteins (COL1A1, fibronectin, and <t>CCN2)</t> were increased in control (Scramble) HKFs following TGF-β1 (10 ng/mL) treatment. Knockdown of TXNDC5 attenuated the upregulation of these fibrogenic markers induced by TGF-β1 in HKFs (n = 5–10). (C) Overexpression of TXNDC5 was sufficient to induce upregulation of fibroblast activation marker (Periostin) and ECM proteins (COL1A1, fibronectin) in HKFs (n = 3–10). (D) Treatment of TGF-β1 (10 ng/mL) increased the cellular proliferation activity of HKFs, which was abrogated by TXNDC5 knockdown. (E) Overexpression of TXNDC5 increased the cellular proliferation activity of HKFs. In D and E, n = 10. Data are representative of 3 or more independent experimental replicates. For all panels, data are presented as mean ± SEM. The statistical significance of differences for 2 groups was determined by 2-sided t test and among 3 or more groups it was determined using 1-way ANOVA, followed by Sidak’s post hoc tests. *P < 0.05, **P < 0.01, ***P < 0.001.
Aortas, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/col1a1/pmc05931129-611-3-12?v=OriGene
Average 90 stars, based on 1 article reviews
aortas - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
OriGene rabbit anti type iii collagen
(A) Protein and (B) transcript expression levels of fibroblast activation marker (periostin) and ECM proteins (COL1A1, fibronectin, and <t>CCN2)</t> were increased in control (Scramble) HKFs following TGF-β1 (10 ng/mL) treatment. Knockdown of TXNDC5 attenuated the upregulation of these fibrogenic markers induced by TGF-β1 in HKFs (n = 5–10). (C) Overexpression of TXNDC5 was sufficient to induce upregulation of fibroblast activation marker (Periostin) and ECM proteins (COL1A1, fibronectin) in HKFs (n = 3–10). (D) Treatment of TGF-β1 (10 ng/mL) increased the cellular proliferation activity of HKFs, which was abrogated by TXNDC5 knockdown. (E) Overexpression of TXNDC5 increased the cellular proliferation activity of HKFs. In D and E, n = 10. Data are representative of 3 or more independent experimental replicates. For all panels, data are presented as mean ± SEM. The statistical significance of differences for 2 groups was determined by 2-sided t test and among 3 or more groups it was determined using 1-way ANOVA, followed by Sidak’s post hoc tests. *P < 0.05, **P < 0.01, ***P < 0.001.
Rabbit Anti Type Iii Collagen, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/col1a1/10__1089_slash_ten__tec__2013__0258-110-26-30?v=OriGene
Average 90 stars, based on 1 article reviews
rabbit anti type iii collagen - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Revvity col1a1
(A) Protein and (B) transcript expression levels of fibroblast activation marker (periostin) and ECM proteins (COL1A1, fibronectin, and <t>CCN2)</t> were increased in control (Scramble) HKFs following TGF-β1 (10 ng/mL) treatment. Knockdown of TXNDC5 attenuated the upregulation of these fibrogenic markers induced by TGF-β1 in HKFs (n = 5–10). (C) Overexpression of TXNDC5 was sufficient to induce upregulation of fibroblast activation marker (Periostin) and ECM proteins (COL1A1, fibronectin) in HKFs (n = 3–10). (D) Treatment of TGF-β1 (10 ng/mL) increased the cellular proliferation activity of HKFs, which was abrogated by TXNDC5 knockdown. (E) Overexpression of TXNDC5 increased the cellular proliferation activity of HKFs. In D and E, n = 10. Data are representative of 3 or more independent experimental replicates. For all panels, data are presented as mean ± SEM. The statistical significance of differences for 2 groups was determined by 2-sided t test and among 3 or more groups it was determined using 1-way ANOVA, followed by Sidak’s post hoc tests. *P < 0.05, **P < 0.01, ***P < 0.001.
Col1a1, supplied by Revvity, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/col1a1/pmc07080756-194-4-9?v=Revvity
Average 90 stars, based on 1 article reviews
col1a1 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


TGF-β secreted from the hiPSC-derived CM patch induced Col1a1 expression but not Col3a1 (A) Schematic representation of the co-culture system. hiPSC-derived CMs were seeded on the upper chamber, whereas the cardiac fibroblasts isolated from mice heart were cultured at the lower chamber in the presence and absence of SB431542, a TGF-β receptor inhibitor. (B) RT-qPCR analysis of Col1a1 , Col3a1 , and Pai1 in the cultured cardiac fibroblasts. Two-way ANOVA (co-culture × inhibitor) with interaction; Tukey-adjusted post hoc tests on estimated marginal means. Data represent mean ± SEM. N = 3–6, one-way ANOVA followed by Tukey’s HSD test, p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

Journal: iScience

Article Title: Human iPSC cardiomyocyte patch transplantation modifies extracellular matrix and fibroblast behavior after myocardial infarction

doi: 10.1016/j.isci.2026.115341

Figure Lengend Snippet: TGF-β secreted from the hiPSC-derived CM patch induced Col1a1 expression but not Col3a1 (A) Schematic representation of the co-culture system. hiPSC-derived CMs were seeded on the upper chamber, whereas the cardiac fibroblasts isolated from mice heart were cultured at the lower chamber in the presence and absence of SB431542, a TGF-β receptor inhibitor. (B) RT-qPCR analysis of Col1a1 , Col3a1 , and Pai1 in the cultured cardiac fibroblasts. Two-way ANOVA (co-culture × inhibitor) with interaction; Tukey-adjusted post hoc tests on estimated marginal means. Data represent mean ± SEM. N = 3–6, one-way ANOVA followed by Tukey’s HSD test, p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001.

Article Snippet: Then proteins were analyzed using primary antibodies for Col1a1 (R1038, OriGene, Rockville, MD), Col3a1(ab6310, Abcam, Cambridge, UK) and Gapdh (AM4300, Thermo Fisher Scienctific, Waltham, MA), respectively on Amersham Imager 600 (GE Healthcare, Chicago, IL).

Techniques: Derivative Assay, Expressing, Co-Culture Assay, Isolation, Cell Culture, Quantitative RT-PCR

(A) Protein and (B) transcript expression levels of fibroblast activation marker (periostin) and ECM proteins (COL1A1, fibronectin, and CCN2) were increased in control (Scramble) HKFs following TGF-β1 (10 ng/mL) treatment. Knockdown of TXNDC5 attenuated the upregulation of these fibrogenic markers induced by TGF-β1 in HKFs (n = 5–10). (C) Overexpression of TXNDC5 was sufficient to induce upregulation of fibroblast activation marker (Periostin) and ECM proteins (COL1A1, fibronectin) in HKFs (n = 3–10). (D) Treatment of TGF-β1 (10 ng/mL) increased the cellular proliferation activity of HKFs, which was abrogated by TXNDC5 knockdown. (E) Overexpression of TXNDC5 increased the cellular proliferation activity of HKFs. In D and E, n = 10. Data are representative of 3 or more independent experimental replicates. For all panels, data are presented as mean ± SEM. The statistical significance of differences for 2 groups was determined by 2-sided t test and among 3 or more groups it was determined using 1-way ANOVA, followed by Sidak’s post hoc tests. *P < 0.05, **P < 0.01, ***P < 0.001.

Journal: The Journal of Clinical Investigation

Article Title: Endoplasmic reticulum protein TXNDC5 promotes renal fibrosis by enforcing TGF- β signaling in kidney fibroblasts

doi: 10.1172/JCI143645

Figure Lengend Snippet: (A) Protein and (B) transcript expression levels of fibroblast activation marker (periostin) and ECM proteins (COL1A1, fibronectin, and CCN2) were increased in control (Scramble) HKFs following TGF-β1 (10 ng/mL) treatment. Knockdown of TXNDC5 attenuated the upregulation of these fibrogenic markers induced by TGF-β1 in HKFs (n = 5–10). (C) Overexpression of TXNDC5 was sufficient to induce upregulation of fibroblast activation marker (Periostin) and ECM proteins (COL1A1, fibronectin) in HKFs (n = 3–10). (D) Treatment of TGF-β1 (10 ng/mL) increased the cellular proliferation activity of HKFs, which was abrogated by TXNDC5 knockdown. (E) Overexpression of TXNDC5 increased the cellular proliferation activity of HKFs. In D and E, n = 10. Data are representative of 3 or more independent experimental replicates. For all panels, data are presented as mean ± SEM. The statistical significance of differences for 2 groups was determined by 2-sided t test and among 3 or more groups it was determined using 1-way ANOVA, followed by Sidak’s post hoc tests. *P < 0.05, **P < 0.01, ***P < 0.001.

Article Snippet: COL1A1 (1:1000, Aviva Systems Biology, OAAB10798, for mouse species), COL1A1 (1:1000, OriGene, TA309096, for human species), CCN2, TGFBR2 (1:1000, OriGene, TA323092, TA311643), POSTN, ATF6, N-cadherin (1:1000, 1:1000, 1:3000, GeneTex, GTX100602, GTX104820, GTX127345), FN1 (1:1000, BD Biosciences, 610077), TXNDC5, β-tubulin (1:30000, 1:5000, Proteintech, 19834-1-AP, 66240-1-Ig), BiP (1:1000, Cell Signaling Technology, 3177), p-SMAD3 (1:1000, Abcam, ab40854), total-SMAD3 (1:1000, Cell Signaling Technology, 9523, for mouse species), total-SMAD3 (1:1000, Abcam, ab52903, for human species), TGFBR1 (1:1000, Thermo Fisher Scientific, PA5-32631, for human species), TGFBR1 (1:1000, Abcam, ab31013, for mouse species), and GAPDH (1:5000, Thermo Fisher Scientific, MA5-15738).

Techniques: Expressing, Activation Assay, Marker, Control, Knockdown, Over Expression, Activity Assay

(A) Illustration of experimental design to induce Txndc5 deletion specifically in renal fibroblasts. (B) Picrosirius red staining of kidney sections from WT and Txndc5cKO mice 10 days after UUO (n = 6–7). Scale bar: 50 μm. (C) Immunoblots to quantify fibroblast activation marker (POSTN) and ECM (COL1A1 and CCN2) proteins in whole-kidney lysates from Col1a2-Cre and Txndc5cKO mice 10 days after UUO (n = 5–6). (D) SHG images of kidney sections from Col1a2-Cre and Txndc5cKO mice 10 days after UUO. The quantitative results of SHG-positive areas showed accumulation of fibrillar collagen in Col1a2-Cre kidneys, which was ameliorated in Txndc5cKO mice (n = 3). Scale bar: 50 μm. Data are representative of 3 or more independent experimental replicates. For all panels, data are presented as mean ± SEM. The statistical significance of differences among 3 or more groups was determined using 1-way ANOVA, followed by Sidak’s post hoc tests. *P < 0.05, **P < 0.01, ***P < 0.001.

Journal: The Journal of Clinical Investigation

Article Title: Endoplasmic reticulum protein TXNDC5 promotes renal fibrosis by enforcing TGF- β signaling in kidney fibroblasts

doi: 10.1172/JCI143645

Figure Lengend Snippet: (A) Illustration of experimental design to induce Txndc5 deletion specifically in renal fibroblasts. (B) Picrosirius red staining of kidney sections from WT and Txndc5cKO mice 10 days after UUO (n = 6–7). Scale bar: 50 μm. (C) Immunoblots to quantify fibroblast activation marker (POSTN) and ECM (COL1A1 and CCN2) proteins in whole-kidney lysates from Col1a2-Cre and Txndc5cKO mice 10 days after UUO (n = 5–6). (D) SHG images of kidney sections from Col1a2-Cre and Txndc5cKO mice 10 days after UUO. The quantitative results of SHG-positive areas showed accumulation of fibrillar collagen in Col1a2-Cre kidneys, which was ameliorated in Txndc5cKO mice (n = 3). Scale bar: 50 μm. Data are representative of 3 or more independent experimental replicates. For all panels, data are presented as mean ± SEM. The statistical significance of differences among 3 or more groups was determined using 1-way ANOVA, followed by Sidak’s post hoc tests. *P < 0.05, **P < 0.01, ***P < 0.001.

Article Snippet: COL1A1 (1:1000, Aviva Systems Biology, OAAB10798, for mouse species), COL1A1 (1:1000, OriGene, TA309096, for human species), CCN2, TGFBR2 (1:1000, OriGene, TA323092, TA311643), POSTN, ATF6, N-cadherin (1:1000, 1:1000, 1:3000, GeneTex, GTX100602, GTX104820, GTX127345), FN1 (1:1000, BD Biosciences, 610077), TXNDC5, β-tubulin (1:30000, 1:5000, Proteintech, 19834-1-AP, 66240-1-Ig), BiP (1:1000, Cell Signaling Technology, 3177), p-SMAD3 (1:1000, Abcam, ab40854), total-SMAD3 (1:1000, Cell Signaling Technology, 9523, for mouse species), total-SMAD3 (1:1000, Abcam, ab52903, for human species), TGFBR1 (1:1000, Thermo Fisher Scientific, PA5-32631, for human species), TGFBR1 (1:1000, Abcam, ab31013, for mouse species), and GAPDH (1:5000, Thermo Fisher Scientific, MA5-15738).

Techniques: Staining, Western Blot, Activation Assay, Marker

(A) Picrosirius red staining of kidney sections from WT and Txndc5cKO mice 28 days after uIRI (n = 7–11). Scale bar: 50 μm. (B) Immunoblots to quantify fibroblast activation marker (POSTN) and ECM (COL1A1 and CCN2) proteins in whole-kidney lysates from Col1a2-Cre and Txndc5cKO mice 28 days after uIRI (n = 4–11). (C) SHG images of kidney sections from Col1a2-Cre and Txndc5cKO mice 28 days after uIRI. The quantitative results of SHG-positive areas showed accumulation of fibrillar collagen in Col1a2-Cre kidneys, which was ameliorated in Txndc5cKO mice (n = 3). Scale bar: 50 μm. Data are representative of 3 or more independent experimental replicates. For all panels, data are presented as mean ± SEM. The statistical significance of differences among 3 or more groups was determined using 1-way ANOVA, followed by Sidak’s post hoc tests. **P < 0.01, ***P < 0.001.

Journal: The Journal of Clinical Investigation

Article Title: Endoplasmic reticulum protein TXNDC5 promotes renal fibrosis by enforcing TGF- β signaling in kidney fibroblasts

doi: 10.1172/JCI143645

Figure Lengend Snippet: (A) Picrosirius red staining of kidney sections from WT and Txndc5cKO mice 28 days after uIRI (n = 7–11). Scale bar: 50 μm. (B) Immunoblots to quantify fibroblast activation marker (POSTN) and ECM (COL1A1 and CCN2) proteins in whole-kidney lysates from Col1a2-Cre and Txndc5cKO mice 28 days after uIRI (n = 4–11). (C) SHG images of kidney sections from Col1a2-Cre and Txndc5cKO mice 28 days after uIRI. The quantitative results of SHG-positive areas showed accumulation of fibrillar collagen in Col1a2-Cre kidneys, which was ameliorated in Txndc5cKO mice (n = 3). Scale bar: 50 μm. Data are representative of 3 or more independent experimental replicates. For all panels, data are presented as mean ± SEM. The statistical significance of differences among 3 or more groups was determined using 1-way ANOVA, followed by Sidak’s post hoc tests. **P < 0.01, ***P < 0.001.

Article Snippet: COL1A1 (1:1000, Aviva Systems Biology, OAAB10798, for mouse species), COL1A1 (1:1000, OriGene, TA309096, for human species), CCN2, TGFBR2 (1:1000, OriGene, TA323092, TA311643), POSTN, ATF6, N-cadherin (1:1000, 1:1000, 1:3000, GeneTex, GTX100602, GTX104820, GTX127345), FN1 (1:1000, BD Biosciences, 610077), TXNDC5, β-tubulin (1:30000, 1:5000, Proteintech, 19834-1-AP, 66240-1-Ig), BiP (1:1000, Cell Signaling Technology, 3177), p-SMAD3 (1:1000, Abcam, ab40854), total-SMAD3 (1:1000, Cell Signaling Technology, 9523, for mouse species), total-SMAD3 (1:1000, Abcam, ab52903, for human species), TGFBR1 (1:1000, Thermo Fisher Scientific, PA5-32631, for human species), TGFBR1 (1:1000, Abcam, ab31013, for mouse species), and GAPDH (1:5000, Thermo Fisher Scientific, MA5-15738).

Techniques: Staining, Western Blot, Activation Assay, Marker

(A) Illustration of experimental design to induce Txndc5 deletion specifically in renal fibroblasts in mouse kidneys with established fibrosis. (B) Picrosirius red staining of kidney sections from Col1a2-Cre and Txndc5cKO mice. Ten days after UUO, Col1a2-Cre and Txndc5cKO mice showed a similar extent of renal fibrosis prior to tamoxifen injection. Eleven days after tamoxifen treatment, the fibrotic areas more than doubled (increased from 5.1% to 10.6%) in Col1a2-Cre, but barely changed in Txndc5cKO (changed from 5.3% to 6.9%) mouse kidneys (n = 5–6). Scale bar: 50 μm. (C) Protein expression levels of fibroblast activation marker (periostin), ECM (CCN2), and TGFBR1 in whole-kidney lysate from Col1a2-Cre and Txndc5cKO mice (n = 4–6). (D) Schematic summary of the proposed profibrotic mechanisms by which TXNDC5 contributes to the pathogenesis of renal fibrosis. TF: transcription factor. Data are representative of 3 or more independent experimental replicates. For all panels, data are presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 by 2-sided t test.

Journal: The Journal of Clinical Investigation

Article Title: Endoplasmic reticulum protein TXNDC5 promotes renal fibrosis by enforcing TGF- β signaling in kidney fibroblasts

doi: 10.1172/JCI143645

Figure Lengend Snippet: (A) Illustration of experimental design to induce Txndc5 deletion specifically in renal fibroblasts in mouse kidneys with established fibrosis. (B) Picrosirius red staining of kidney sections from Col1a2-Cre and Txndc5cKO mice. Ten days after UUO, Col1a2-Cre and Txndc5cKO mice showed a similar extent of renal fibrosis prior to tamoxifen injection. Eleven days after tamoxifen treatment, the fibrotic areas more than doubled (increased from 5.1% to 10.6%) in Col1a2-Cre, but barely changed in Txndc5cKO (changed from 5.3% to 6.9%) mouse kidneys (n = 5–6). Scale bar: 50 μm. (C) Protein expression levels of fibroblast activation marker (periostin), ECM (CCN2), and TGFBR1 in whole-kidney lysate from Col1a2-Cre and Txndc5cKO mice (n = 4–6). (D) Schematic summary of the proposed profibrotic mechanisms by which TXNDC5 contributes to the pathogenesis of renal fibrosis. TF: transcription factor. Data are representative of 3 or more independent experimental replicates. For all panels, data are presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 by 2-sided t test.

Article Snippet: COL1A1 (1:1000, Aviva Systems Biology, OAAB10798, for mouse species), COL1A1 (1:1000, OriGene, TA309096, for human species), CCN2, TGFBR2 (1:1000, OriGene, TA323092, TA311643), POSTN, ATF6, N-cadherin (1:1000, 1:1000, 1:3000, GeneTex, GTX100602, GTX104820, GTX127345), FN1 (1:1000, BD Biosciences, 610077), TXNDC5, β-tubulin (1:30000, 1:5000, Proteintech, 19834-1-AP, 66240-1-Ig), BiP (1:1000, Cell Signaling Technology, 3177), p-SMAD3 (1:1000, Abcam, ab40854), total-SMAD3 (1:1000, Cell Signaling Technology, 9523, for mouse species), total-SMAD3 (1:1000, Abcam, ab52903, for human species), TGFBR1 (1:1000, Thermo Fisher Scientific, PA5-32631, for human species), TGFBR1 (1:1000, Abcam, ab31013, for mouse species), and GAPDH (1:5000, Thermo Fisher Scientific, MA5-15738).

Techniques: Staining, Injection, Expressing, Activation Assay, Marker